Direct-Acting Antiviral Agents for the Treatment of Hepatitis C Virus Infection
Abstract
The design and development of direct-acting antiviral agents that when used in combination cure chronic hepatitis C virus (HCV) infection after 8–24 weeks of therapy are the result of 20 years of intense drug discovery and development effort. Compounds that interfere with the function of every protein expressed by the virus have been characterized, but only inhibitors of the NS3 protease, the NS5A replication complex protein, and the NS5B...
Paper Details
Title
Direct-Acting Antiviral Agents for the Treatment of Hepatitis C Virus Infection
Published Date
Jan 1, 2017
Journal
Pages
553 - 627
Citation AnalysisPro
You’ll need to upgrade your plan to Pro
Looking to understand the true influence of a researcher’s work across journals & affiliations?
- Scinapse’s Top 10 Citation Journals & Affiliations graph reveals the quality and authenticity of citations received by a paper.
- Discover whether citations have been inflated due to self-citations, or if citations include institutional bias.
Notes
History